hotspot -WSS

hotspot

author：knowledge 2025-09-07 21:57:41 - browse：38

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： Alkermes shareholders re
Next article： Delta passengers in Vegas fall sick while waiting on flight in triple

explore

WSS

The haunting brain science of long Covid

What it's like to live with paralysis for one psychologist

Dementia risk linked to living in disadvantaged areas: Study

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Why patients can’t get everything they want on drug pricing

Democrats decry new health bill for going easy on private equity

hotspot

hotspot

entertainment

Sports medicine is finally prioritizing gender equality

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Virginia high school admissions case could be legal follow

5 dead in mass shooting on Caribbean island of St. Vincent: Police

United colonoscopy coverage change 'may cost lives,' doctors say

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Medicare details structure of new drug price negotiation program

Judge denies Trump's request for new trial in E. Jean Carroll case

Trump demands the U.S. pay no more for drugs than other countries … again

There’s a way to spot data fakery. All journals should be using it

hotspot

Why patients can’t get everything they want on drug pricing

UHS says company favors patients whose insurance pays more

US jobless claims fall again as labor market continues to flash strength

The stock market has soared this year, but will it last? Experts weigh in

'CMA Fest' 2023: How to watch, who is performing and more

New lawsuit accuses health insurer Cigna of denying claims in bulk

focus

explore

entertainment

hotspot